We found that a drug approved and indicated for aging would conservatively have a peak global market size ~$150-$200 billion annually.
A company that owned only this drug would be more valuable than the top 2 big pharma companies (J&J and Pfizer) in terms of revenue…combined.
age1
211 posts
Backing contrarian founders building breakthrough longevity companies to increase healthy lifespan | @AlexJColville @LauraDeming
age1.com/careers
- We launched... again! Thanks to all who came to our event at JPM 2024 - our GP @AlexJColville and team tip our hats off to you 😀
- 20 years ago, scientists figured out how to make mice live 150% longer by altering one singular gene. What have we learned since this groundbreaking discovery? In our debut video, @alexkesin seeks to find out.
00:00 - Confirmed: @loyalfordogs just got a shoutout at the Emmys! Before our very eyes, we're starting to see public acceptance of aging drugs. @celinehalioua is truly a phenom. We are proud and thrilled of what she and Loyal are accomplishing every day.
00:00CAN SOMEONE TELL ME IF WE ACTUALLY JUST GOT A SHOUT OUT AT THE EMMYS?????? - As we ring in the new year, the age1 team has put together a New Year’s Company Wish List of ideas we’d love to see future founders work on. We want exceptional founders to work on achieving healthy lifespan extension in the next decade.
- Join us in SF for an in-person journal club on synbio x aging biology:One of my bio grievances is how disconnected synbio tools and aging space are. To draw connections between these fields, I’m assembling a subgroup of folks interested in doing a series of journal clubs on writing & editing biology (esp. aging biology). See image for questions
- Replying to @age1vcThe economics of delivering such value to human health at scale are unprecedented:
- Replying to @age1vcAn aging drug is a drug that has been rigorously shown to increase healthy lifespan in people, with emphasis on the ability of such an intervention to extend quality of life. It could allow older adults to enjoy a higher quality of life, for longer.
- Keep your eyes and ears peeled! We're releasing our first video this Friday at 10 am PST. Written and produced by @alexkesin.
- We're proud to share our ambitious plan to get an aging drug on pharmacy shelves within a decade. Introducing the Longevity Funnel Framework (LFF), spearheaded by our very own @maggie_1i.
- Happy Lunar New Year! To celebrate, we’re giving away some books that we love Like + repost for a chance to be one of 5 lucky people to win a brand new book, endorsed by the age1 team!
- Congratulations to @DocMarkerB and @Ryan Sprenger for being awarded a @NASA Innovative Advanced Concepts (NIAC) grant to test the potential of hibernation to protect astronauts from the damaging effects of space travel!
- Richard Miller is a renowned figure in our field. We're delighted to soon share a new series focused on the latest developments in longevity biotech. We'll kick off with a special feature on the Interventions Testing Program, including insights from Dr. Miller himself.In today's episode (Ep. #281) of The Drive, I speak with Rich Miller, M.D., Ph.D, the Director of the Center for Aging Research at the University of Michigan. We delve into potential life-extending interventions in mice and more. bit.ly/46GaCcy
- age1 hits Boston! We had a blast cohosting an awesome crew for our longevity event with @StrandTx - hopefully we'll be back soon!


















